Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
Following the cardiovascular safety review of all NSAIDs and concerns regarding the risk of hepatotoxicity, the Office of Product Review (OPR) conducted a full safety review of diclofenac.